1,073 results on '"Lorenzi M"'
Search Results
2. The Use of Full-Contour Zirconia for Full-Arch Implant-Supported Rehabilitations—A Narrative Review
3. Exploiting plant biodiversity to tackle colorectal cancer and non-alcoholic fatty liver disease
4. Regional flux analysis for discovering and quantifying anatomical changes: An application to the brain morphometry in Alzheimer's disease
5. WASPnest : a worldwide assessment of social Polistine nesting behavior
6. The St. Antonino tunnel reconstruction after the great collapse that had occurred on December 2007
7. Cuticular hydrocarbons as cues of sex and health condition in Polistes dominula wasps
8. The St. Antonino tunnel reconstruction after the great collapse that had occurred on December 2007
9. Children with Aniridia and Healthcare Systems: From Needs Assessment to a Comprehensive Program of Care and Assistance
10. 21P Bevacizumab plus atezolizumab and chemotherapy in NSCLC harbouring EGFR mutation previously treated with EGFR tyrosine kinase inhibitor: The BACH-NET study
11. P13 Disease-Free Survival as a Potential Surrogate Endpoint for Overall Survival in Patients With Early-Stage Non-Small Cell Lung Cancer: A Systematic Literature Review and Meta-Analyses
12. FLamby:Datasets and Benchmarks for Cross-Silo Federated Learning in Realistic Healthcare Settings
13. 1584P Immune-related adverse events (irAEs) in advanced non-small cell lung cancer (aNSCLC) in a real-world analysis: A risk prediction nomogram
14. P1.15-06 Immune-Checkpoint Inhibitors-Related Colitis in Advanced Non-small Cell Lung Cancer Patients: A Real-World Analysis
15. EP08.01-012 First-line Chemo-Immunotherapy in Advanced Non-Small Cell Lung Cancer with 0-49% PD-L1: A Real-world Experience
16. 19P Gene expression profile (GEP) of extensive small-cell lung cancer (eSCLC) patients (pts) receiving first-line platinum-etoposide plus atezolizumab (PEA)
17. EP08.02-104 Osimertinib in Untreated EGFR-Mutant Non-small Cell Lung Cancers: Overall Survival and Budget Impact Analysis in Real-World
18. Cuckoo wasps manipulate foraging and resting activities in their hosts
19. Application of X-ray micro-computed tomography on high-speed cavitating diesel fuel flows
20. LCC-Demons: A robust and accurate symmetric diffeomorphic registration algorithm
21. In Between Breeding Systems : Neither Dioecy Nor Androdioecy Explains Sexual Polymorphism in Functionally Dioecious Worms
22. Labile Sex Expression and the Evolution of Dioecy in Ophryotrocha Polychaete Worms
23. Prediction of thrombosis in atrial fibrillation with compact atrial shape representation
24. Long-term remodelling and arrhythmogenicity after myocardial infarction using a novel image-based estimator: the Scar Maturation Score
25. 40P Immune-related adverse events (irAEs) in advanced non-small cell lung cancer (aNSCLC) patients (pts): A real-world analysis
26. 63P Immune-related adverse events (irAEs) in advanced non-small cell lung cancer (aNSCLC) patients (pts): Neutrophil to lymphocyte ratio (NLR) and the risk for toxicity recurrence
27. THE GEOGRAPHIC STRUCTURE OF SELECTION ON A COEVOLVING INTERACTION BETWEEN SOCIAL PARASITIC WASPS AND THEIR HOSTS HAMPERS SOCIAL EVOLUTION
28. L’impatto dell’uso dei trattamenti non compresi nelle classi di rimborsabilità nella presa in carico dei malati rari: uno studio in campo reale [The impact of the use of treatments not included in the reimbursement classes in the care of rare patients: a real world study]
29. The sarcopenia and physical frailty in older people: multi-component treatment strategies (SPRINTT) project: description and feasibility of a nutrition intervention in community-dwelling older Europeans
30. Bateman Gradients in Hermaphrodites: An Extended Approach to Quantify Sexual Selection
31. Quality of life in advanced colorectal cancer
32. Geographic Variation in Air Temperature Leads to Intraspecific Variability in the Behavior and Productivity of a Eusocial Insect
33. Non-small cell lung cancer (NSCLC) patients with rare or complex epidermal growth factor receptor (EGFR) mutations: A single institution series: 166P
34. Enrichment through biomarkers in clinical trials of Alzheimer's drugs in patients with mild cognitive impairment
35. The Blood-Brain Barrier in Diabetes Mellitus
36. 1157P Diagnostic therapeutic pathway (DTP) of early stage non-small cell lung cancer (eNSCLC): A real-world focus on EGFR status detection in resected patients (pts)
37. Regional flux analysis for discovering and quantifying anatomical changes: An application to the brain morphometry in Alzheimerʼs disease
38. Network meta-analysis of direct-acting antivirals in combination with peginterferon–ribavirin for previously untreated patients with hepatitis C genotype 1 infection
39. Detection of circulating immunosuppressive cytokines in malignant pleural mesothelioma patients for prognostic stratification
40. Poor Odors, Strength, and Persistence Give Their Rewards to Mutilla europaea Visiting Dangerous Wasp Nests
41. Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines
42. OCT Signal Enhancement with Deep Learning.
43. Characterization of BMS-911543, a functionally selective small-molecule inhibitor of JAK2
44. 2021P Cell-free (cf) DNA as predictive biomarker (B) of treatment outcome in extensive small cell lung cancer (eSCLC) patients (pts) receiving atezolizumab, carboplatin and etoposide (ACE): CATS/ML43257 study
45. 2020P Circulating micro RNAs (cmiRNAs) as treatment outcome predictors in extensive small cell lung cancer (eSCLC) patients (pts) receiving atezolizumab plus carboplatin and etoposide (ACE): CATS/ML43257 study
46. Colony kin structure and breeding patterns in the social wasp, Polistes biglumis
47. Increased prevalence of proliferative retinopathy in patients with type 1 diabetes who are deficient in glucose-6-phosphate dehydrogenase
48. Social wasps without workers: geographic variation of caste expression in the paper wasp Polistes biglumis
49. Kinase drug discovery approaches in chronic myeloproliferative disorders
50. 149P First-line (1L) osimertinib in EGFR mutant (mut) advanced non-small cell lung cancer (aNSCLC) patients (pts): Progression (PD) pattern and safety in the real-world (RW)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.